Events

Moderator:  Kathy Talkington, Director Health Programs, Pew Charitable Trust Speakers: Colm Leonard – Clinical Advisor/Consultant, NICE Kevin Outterson – Professor of Law & Executive Director, CARB-X Elmar Nimmesgern – Secretariat Lead, Global AMR R&D Hub Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta

As the scientific community search for alternatives to broad spectrum antibiotics, phage therapy has re-emerged as a viable solution to tackle the global health challenge of anti-microbial resistance. As such, the 2nd Bacteriophage Therapy Summit returns digitally as a dedicated platform for leaders in industry and academia to accelerate the discovery and translation of bacteriophage research into targeted […]

Moderator: Betsy Wonderly Trainor, Alliance Director, CARB-X Speakers: Peter Haug – CFO & Co-Founder, Head of Business Development & Licensing, Noscendo GmbH Piotr Gastrecki – CTO, ScopeFluidics Rosemarie Preyer – GenID GmbH

The September PACCARB meeting, held virtually, will focus on welcoming eight new liaison members and on the impact of COVID-19 and its affect on antimicrobial resistance (AMR). Topics will include presentations on the COVID-19 mortality rate due to secondary acquired infections, antibiotic stewardship practices during a pandemic, disruptions in the agricultural industry due to COVID-19 […]

Speakers include Cameron Bess, Project Officer, Antibacterials Branch, Division of CBRN Medical Countermeasures, BARDA. Turning a good scientific idea into a successful biotech startup is a challenging journey.This panel will highlight several successful paths that scientists can take toward creating a successful biotech company. Learn what New York-area resources are available to turn your idea […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

Participants include Kevin Outterson, Executive Director of CARB-X. The world needs a new generation of antibiotics to address the rapid growth in antibiotic-resistant bacteria. The UK government’s 2014 Review on Antimicrobial Resistance estimated that such bacteria could result in the deaths of 10 million people a year by 2050 and an accumulated cost of up […]

Speakers include Kevin Outterson, Executive Director of CARB-X. The ESCMID Conference on Coronavirus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020 and will cover all aspects of COVID-19. ECCVID will feature a comprehensive scientific programme that will span a wide range of topics surrounding this emerging threat.  COVID-19 is a major […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

Speakers: Value of a pre-IND interaction with the US FDA during late lead optimization: Bugworks experience - Bala Subramanian, Bugworks Research Inc. Amicidins: Building clinical and regulatory strategies for non-traditional products to prevent and treat life-threatening infections - Michael P. Bevilacqua, Amicrobe, Inc. Discovery and development of microbiome therapeutics using reverse translation - Matthew Henn […]